Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Kwapiszewska

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cellular Signalling|September 2, 2019
Transcription factor Fra-2 and its emerging role in matrix deposition, proliferation and inflammation in chronic lung diseasesA Birnhuber, V Biasin, D Schnoegl, et al.
Pneumologie (Stuttgart, Germany)|April 7, 2016
[Pulmonary (Arterial) Hypertension]G Kwapiszewska, J Hoffmann, G Kovacs, et al.
Pneumologie (Stuttgart, Germany)|May 12, 2016
[Research in Austria - the Ludwig Boltzmann Institute for Lung Vascular Research]G Kovacs, D Kleinschek, G Kwapiszewska, et al.
Scientific Reports|January 7, 2017
Meprin β contributes to collagen deposition in lung fibrosisV Biasin, M Wygrecka, L M Marsh, et al.
The European Respiratory Journal|June 8, 2010
Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertensionV S Nikam, R T Schermuly, R Dumitrascu, et al.
The European Respiratory Journal|June 14, 2008
Shroom expression is attenuated in pulmonary arterial hypertensionJ Sevilla-Pérez, M Königshoff, G Kwapiszewska, et al.
Thrombosis and Haemostasis|September 19, 2014
Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatmentC Veith, D Zakrzewicz, B K Dahal, et al.
The European Respiratory Journal|March 30, 2007
The transforming growth factor-beta/Smad2,3 signalling axis is impaired in experimental pulmonary hypertensionA Zakrzewicz, F M Kouri, B Nejman, et al.
British Journal of Pharmacology|May 1, 2014
NPY/Y₁ receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertensionS Crnkovic, B Egemnazarov, P Jain, et al.
Deutsche Medizinische Wochenschrift (1946)|October 21, 2016
[Pathobiology, pathology and genetics of pulmonary hypertension: Recommendations of the Cologne Consensus Conference 2016]A Olschewski, E M Berghausen, C A Eichstaedt, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cellular Signalling|September 2, 2019
Transcription factor Fra-2 and its emerging role in matrix deposition, proliferation and inflammation in chronic lung diseasesA Birnhuber, V Biasin, D Schnoegl, et al.
Pneumologie (Stuttgart, Germany)|April 7, 2016
[Pulmonary (Arterial) Hypertension]G Kwapiszewska, J Hoffmann, G Kovacs, et al.
Pneumologie (Stuttgart, Germany)|May 12, 2016
[Research in Austria - the Ludwig Boltzmann Institute for Lung Vascular Research]G Kovacs, D Kleinschek, G Kwapiszewska, et al.
Scientific Reports|January 7, 2017
Meprin β contributes to collagen deposition in lung fibrosisV Biasin, M Wygrecka, L M Marsh, et al.
The European Respiratory Journal|June 8, 2010
Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertensionV S Nikam, R T Schermuly, R Dumitrascu, et al.
The European Respiratory Journal|June 14, 2008
Shroom expression is attenuated in pulmonary arterial hypertensionJ Sevilla-Pérez, M Königshoff, G Kwapiszewska, et al.
Thrombosis and Haemostasis|September 19, 2014
Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatmentC Veith, D Zakrzewicz, B K Dahal, et al.
The European Respiratory Journal|March 30, 2007
The transforming growth factor-beta/Smad2,3 signalling axis is impaired in experimental pulmonary hypertensionA Zakrzewicz, F M Kouri, B Nejman, et al.
British Journal of Pharmacology|May 1, 2014
NPY/Y₁ receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertensionS Crnkovic, B Egemnazarov, P Jain, et al.
Deutsche Medizinische Wochenschrift (1946)|October 21, 2016
[Pathobiology, pathology and genetics of pulmonary hypertension: Recommendations of the Cologne Consensus Conference 2016]A Olschewski, E M Berghausen, C A Eichstaedt, et al.
Pageof 1